Low-Level Doxorubicin Resistance in Benzo[a]pyrene-Treated KB-3-1 Cells Is Associated with Increased LRP Expression and Altered Subcellular Drug Distribution
- 15 April 2000
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 164 (2), 134-142
- https://doi.org/10.1006/taap.2000.8903
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Divergent mechanisms for loss of Ah-responsiveness in benzo[a]pyrene- and adriamycinr-resistant MCF-7 cellsBiochemical Pharmacology, 1999
- Major vault protein of electric ray is a phosphoprotein.Neurochemical Research, 1998
- Characterization of the Sea Urchin Major Vault Protein: A Possible Role for Vault Ribonucleoprotein Particles in Nucleocytoplasmic TransportDevelopmental Biology, 1997
- Decreased sensitivity to adriamycin in cadmium-resistant human lung carcinoma A549 cellsBiochemical Pharmacology, 1997
- Protein kinase C: a worthwhile target for anticancer drugs?Anti-Cancer Drugs, 1997
- Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cellsBritish Journal of Cancer, 1995
- Modulation of adriamycin® accumulation and efflux by flavonoids in HCT-15 colon cellsBiochemical Pharmacology, 1994
- Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell linesBritish Journal of Cancer, 1993
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984